Not medical advice. This website is not medical advice, a diagnosis, a match to a trial, or a recommendation to join a study. Listings are plain-English rewrites of public ClinicalTrials.gov records. Whether a site is still enrolling, and whether you qualify, can only be confirmed by the study team and your clinician. Source registry: ClinicalTrials.gov. Editorial rules: methodology.
PlainTrials
RecruitingNot a traditional drug phaseinterventionalRules rewrite

Not a traditional drug phase: electroencephalography, electrocardiogram, pupillometry, evoked potentials, light administration for Refractory Epilepsy

Vagus nerve stimulation (VNS) is an added on top of your current treatment treatment for refractory epilepsy. Although widely used, there is still a substantial number of patients with insufficient response.

Official registry: https://clinicaltrials.gov/study/NCT06304389 · Cliniques universitaires Saint-Luc- Université Catholique de Louvain · enrollment listed as 34

What this phase means

This study does not use the classic phase 1–4 drug ladder. It may be a device, a behavior program, a surgery timing study, or an early feasibility test.

Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.

What the registry says happens

If you join, the listed intervention(s) are electroencephalography, electrocardiogram, pupillometry, evoked potentials, light administration, or transcutaneous vagus nerve stimulation, electroencephalography, pupillometry, electrocardiogram, light administration. The registry lists allocation as randomized. Vagus nerve stimulation (VNS) is an added on top of your current treatment treatment for refractory epilepsy.

They plan to enroll about 34 people at Woluwe-Saint-Lambert. Taking part typically means study visits and measurements plus check-ins.

Official title (unrewritten)

Effect of Blue Light on Vagus Nerve Stimulation in Patients With Refractory Epilepsy

Interventions: electroencephalography, electrocardiogram, pupillometry, evoked potentials, light administration, transcutaneous vagus nerve stimulation, electroencephalography, pupillometry, electrocardiogram, light administration

Primary outcome (registry wording): Effect of blue light on VNS biomarkers

Who it is for (from inclusion criteria)

  • Ages 18 Years to 60 Years
  • VNS implanted since at least 3 months age \>18-60 years; IQ \>55 on Wechsler scale (normal status or mild cognitive impairment)
  • healthy participants aged between 18 and 35 years without any medical history (neurological / psychiatric disease)

Public study contact (from the registry)

Inci / cakiroglu

+32470612917

inci.cakiroglu@uclouvain.be

Published on ClinicalTrials.gov. Contact them as a possible participant. They decide eligibility.

Sites listed on ClinicalTrials.gov

1 listed

Related recruiting trials in this snapshot

RecruitingNot a traditional drug phaseBethesda, Maryland
Study of Systemic Lupus Erythematosus

This protocol will evaluate patients with systemic lupus erythematosus (SLE) and their relatives to learn more about how the disease develops and changes over time. It will also study genetic factors that make a person susceptible to SLE.

NCT00001372 · Official ClinicalTrials.gov record · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

RecruitingNot a traditional drug phaseWashington D.C., District of Columbia
Familial Mediterranean Fever and Related Disorders: Genetics and Disease Characteristics

This study is designed to explore the genetics and pathophysiology of diseases presenting with intermittent fever, including familial Mediterranean fever, TRAPS, hyper-IgD syndrome, and related diseases. The following individuals may be eligible for this natural history study: 1) patients with known or suspected familial Mediterranean fever, TRAPS, hyper-IgD syndrome or related disorders; 2) relatives of these patients; 3) healthy, normal volunteers 7 years of age or older.

NCT00001373 · Official ClinicalTrials.gov record · National Human Genome Research Institute (NHGRI)

FAQ about this NCT record

Is NCT06304389 still recruiting?

The sponsor posted status “Recruiting” on ClinicalTrials.gov at last ingest. Sites can pause independently. Confirm with the official record and the listed contact.

What phase is NCT06304389?

Not a traditional drug phase. Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.

Can PlainTrials tell me if I qualify for NCT06304389?

No. The inclusion and exclusion lists on this page are readable extracts of the public eligibility block. Only the study team can screen you.

How to read a ClinicalTrials.gov record · Questions to ask the coordinator · Glossary